Don't t that too loud or you might get fired for biodiversity, bioequity, and bioinclusion
February 26, 2025 at 6:04 PM
Don't t that too loud or you might get fired for biodiversity, bioequity, and bioinclusion
Can’t wait to hear about the bioequity and bioinclusion zines
March 3, 2025 at 4:41 PM
Can’t wait to hear about the bioequity and bioinclusion zines
Biodiversity, bioequity, and bioinclusion are now vilified.
bsky.app/profile/trev...
bsky.app/profile/trev...
In an unconscionable decision, the Smithsonian Institute has decided to no longer support the Biodiversity Heritage Library from 1 Jan 2026. Please someone step up and take it over.
Foundations: please step up and take over the Biodiversity Heritage Library (BHL). This is an absolutely essential scanned archive of all of the old journals and books from the 1500s to about 1920. Has been indispensable for my research.
about.biodiversitylibrary.org/call-for-sup...
about.biodiversitylibrary.org/call-for-sup...
July 2, 2025 at 6:16 PM
Biodiversity, bioequity, and bioinclusion are now vilified.
bsky.app/profile/trev...
bsky.app/profile/trev...
"Why are we getting hits for biodiversity but not bioequity or bioinclusion?" - some random DOGE staffer, probably... on the verge of having a critical thought (but of course instead probably to assuming a conspiracy)
February 20, 2025 at 3:55 PM
"Why are we getting hits for biodiversity but not bioequity or bioinclusion?" - some random DOGE staffer, probably... on the verge of having a critical thought (but of course instead probably to assuming a conspiracy)
This implies the existence of bioequity and bioinclusion. That’s wild.
September 9, 2024 at 6:29 PM
This implies the existence of bioequity and bioinclusion. That’s wild.
Register by March 28 to qualify for Advanced Rate discount to our 25th BioEquity Europe.
Why attend? No other #biotech conference has more VCs. We expect another sellout. Please register soon.
www.BioEquityEurope.com
Why attend? No other #biotech conference has more VCs. We expect another sellout. Please register soon.
www.BioEquityEurope.com
Bio€quity Europe 2025
For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today.
www.BioEquityEurope.com
March 11, 2025 at 8:06 PM
Register by March 28 to qualify for Advanced Rate discount to our 25th BioEquity Europe.
Why attend? No other #biotech conference has more VCs. We expect another sellout. Please register soon.
www.BioEquityEurope.com
Why attend? No other #biotech conference has more VCs. We expect another sellout. Please register soon.
www.BioEquityEurope.com
Česko má v biotechnologiích velký potenciál, ale brzdí nás nedostatečná mezinárodní viditelnost a investice, říká ředitelka Prague.bio @iocbtech.bsky.social, Petra Kinzlová. 🧬 Chce to změnit konferencí BioEquity, která se poprvé ve střední a východní Evropě uskuteční v ČR.
👉Více na bit.ly/48uqTWe
👉Více na bit.ly/48uqTWe
November 24, 2025 at 12:02 PM
Česko má v biotechnologiích velký potenciál, ale brzdí nás nedostatečná mezinárodní viditelnost a investice, říká ředitelka Prague.bio @iocbtech.bsky.social, Petra Kinzlová. 🧬 Chce to změnit konferencí BioEquity, která se poprvé ve střední a východní Evropě uskuteční v ČR.
👉Více na bit.ly/48uqTWe
👉Více na bit.ly/48uqTWe
Join us at #BioEquity Europe 2026 for the Regional Host Panel: How to Bring Great Science to Market – The CEE Case.
Julie Proft will join the discussion, moderated by Zuzana Válková, on what makes CEE science investable and how the region can build stronger biotech success.
📅 5 May
🕓 4:00 pm
Julie Proft will join the discussion, moderated by Zuzana Válková, on what makes CEE science investable and how the region can build stronger biotech success.
📅 5 May
🕓 4:00 pm
April 30, 2026 at 8:32 AM
Join us at #BioEquity Europe 2026 for the Regional Host Panel: How to Bring Great Science to Market – The CEE Case.
Julie Proft will join the discussion, moderated by Zuzana Válková, on what makes CEE science investable and how the region can build stronger biotech success.
📅 5 May
🕓 4:00 pm
Julie Proft will join the discussion, moderated by Zuzana Válková, on what makes CEE science investable and how the region can build stronger biotech success.
📅 5 May
🕓 4:00 pm
It'll be great to see everyone in Bruges and discuss some of the amazing progress that Haya Therapeutics is making in the pipeline and platform for finding, validating & drugging chronic disease state reversing targets in the regulatory genome! #BioEquity🧬 ❤️ 🫁 🦀
May 7, 2025 at 12:16 PM
It'll be great to see everyone in Bruges and discuss some of the amazing progress that Haya Therapeutics is making in the pipeline and platform for finding, validating & drugging chronic disease state reversing targets in the regulatory genome! #BioEquity🧬 ❤️ 🫁 🦀
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now? - BeyondLink
Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will
beyondlink.live
June 13, 2026 at 2:24 AM
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now?
Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now? - BeyondLink
Is CMPS a good stock to buy? We came across a bullish thesis on COMPASS Pathways plc on BioEquity Watch’s Substack. In this article, we will summarize the
beyondlink.live
June 13, 2026 at 2:14 AM
Is COMPASS Pathways plc (CMPS) A Good Stock To Buy Now?
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now? - BeyondLink
Is TVTX a good stock to buy? We came across a bullish thesis on Travere Therapeutics, Inc. on BioEquity Watch’s Substack. In this article, we will summarize
beyondlink.live
April 26, 2026 at 3:47 AM
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?
REGENXBIO Inc. (RGNX): A Bull Case Theory
REGENXBIO Inc. (RGNX): A Bull Case Theory - BeyondLINK
We came across a bullish thesis on REGENXBIO Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on RGNX. REGENXBIO
beyondlink.live
January 21, 2026 at 8:54 AM
REGENXBIO Inc. (RGNX): A Bull Case Theory
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory - BeyondLINK
We came across a bullish thesis on Syndax Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis
beyondlink.live
January 21, 2026 at 7:54 AM
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory
In biotech, we ask: will it work?
But the real question is: will it fit patients’ lives?
At BioEquity Europe 2026, the conversation continues on using patient data to guide smarter biotech investments.
#Biotech #PatientEngagement #LifeSciences
@biocentury.bsky.social ky.social
But the real question is: will it fit patients’ lives?
At BioEquity Europe 2026, the conversation continues on using patient data to guide smarter biotech investments.
#Biotech #PatientEngagement #LifeSciences
@biocentury.bsky.social ky.social
May 5, 2026 at 1:59 PM
In biotech, we ask: will it work?
But the real question is: will it fit patients’ lives?
At BioEquity Europe 2026, the conversation continues on using patient data to guide smarter biotech investments.
#Biotech #PatientEngagement #LifeSciences
@biocentury.bsky.social ky.social
But the real question is: will it fit patients’ lives?
At BioEquity Europe 2026, the conversation continues on using patient data to guide smarter biotech investments.
#Biotech #PatientEngagement #LifeSciences
@biocentury.bsky.social ky.social
Speed is biotech’s currency, but what if we move fast without understanding patients? At BioEquity Europe 2026, this question takes center stage. Hear Hayley Chapman and others on making patient engagement a strategic advantage.
May 4–6 | Prague
@biocentury.bsky.social | @derickomisteal.bsky.social
May 4–6 | Prague
@biocentury.bsky.social | @derickomisteal.bsky.social
April 30, 2026 at 12:03 PM
Speed is biotech’s currency, but what if we move fast without understanding patients? At BioEquity Europe 2026, this question takes center stage. Hear Hayley Chapman and others on making patient engagement a strategic advantage.
May 4–6 | Prague
@biocentury.bsky.social | @derickomisteal.bsky.social
May 4–6 | Prague
@biocentury.bsky.social | @derickomisteal.bsky.social
Praha 11. června 2025 (PROTEXT) - Praha se příští rok stane centrem evropského biotechnologického investičního světa.
Tón: : mírně pozitivní
#česko #gdelt
https://www.metro.cz/protext/v-praze-bude-bioequity-nejvetsi-evropska-konference-pro-biotech-investory.A250611_081300_metro-protext_air
Tón: : mírně pozitivní
#česko #gdelt
https://www.metro.cz/protext/v-praze-bude-bioequity-nejvetsi-evropska-konference-pro-biotech-investory.A250611_081300_metro-protext_air
V Praze bude BioEquity, největší evropská konference pro biotech investory - Metro.cz
Praha 11. června 2025 (PROTEXT) - Praha se příští rok stane centrem evropského biotechnologického investičního světa.
www.metro.cz
June 11, 2025 at 9:30 AM
Praha 11. června 2025 (PROTEXT) - Praha se příští rok stane centrem evropského biotechnologického investičního světa.
Tón: : mírně pozitivní
#česko #gdelt
https://www.metro.cz/protext/v-praze-bude-bioequity-nejvetsi-evropska-konference-pro-biotech-investory.A250611_081300_metro-protext_air
Tón: : mírně pozitivní
#česko #gdelt
https://www.metro.cz/protext/v-praze-bude-bioequity-nejvetsi-evropska-konference-pro-biotech-investory.A250611_081300_metro-protext_air
He spoke about the recently concluded BioEquity Europe conference, which was held in Central Europe for the first time ever and aims to streamline the transfer of biotechnological discoveries into practical applications.
#transfer #IOCB #IOCBPrague #IOCBTech #BioEquityEurope
#transfer #IOCB #IOCBPrague #IOCBTech #BioEquityEurope
May 6, 2026 at 6:04 PM
He spoke about the recently concluded BioEquity Europe conference, which was held in Central Europe for the first time ever and aims to streamline the transfer of biotechnological discoveries into practical applications.
#transfer #IOCB #IOCBPrague #IOCBTech #BioEquityEurope
#transfer #IOCB #IOCBPrague #IOCBTech #BioEquityEurope
Christian Groendahl and @evdh.bsky.social will be attending next week's #BioEquity in Bruges🇧🇪.
Reach out to learn more about our recent progress and updates of our pipeline.
#partnering #BioEquityEurope
Reach out to learn more about our recent progress and updates of our pipeline.
#partnering #BioEquityEurope
May 5, 2025 at 11:25 AM
Christian Groendahl and @evdh.bsky.social will be attending next week's #BioEquity in Bruges🇧🇪.
Reach out to learn more about our recent progress and updates of our pipeline.
#partnering #BioEquityEurope
Reach out to learn more about our recent progress and updates of our pipeline.
#partnering #BioEquityEurope
Last Call: Advanced Rate Discount. 26th #BioEquityEurope. Register or apply to present by April 2 to lock in the price. No biotech event has a higher concentration of investors. Visit our website to see the full list of faculty (including ones below). conferences.biocentury.com/bioequity-eu...
April 1, 2026 at 11:34 AM
Last Call: Advanced Rate Discount. 26th #BioEquityEurope. Register or apply to present by April 2 to lock in the price. No biotech event has a higher concentration of investors. Visit our website to see the full list of faculty (including ones below). conferences.biocentury.com/bioequity-eu...
Connect with us at #BioEquity Europe in Prague.
As organ-on-chip technology continues to advance, it is reshaping how complex biological systems are studied. Meet Wolfgang and Knut to discuss how our solutions can improve pre-clinical decision making and accelerate workflows.
As organ-on-chip technology continues to advance, it is reshaping how complex biological systems are studied. Meet Wolfgang and Knut to discuss how our solutions can improve pre-clinical decision making and accelerate workflows.
April 29, 2026 at 7:18 AM
Connect with us at #BioEquity Europe in Prague.
As organ-on-chip technology continues to advance, it is reshaping how complex biological systems are studied. Meet Wolfgang and Knut to discuss how our solutions can improve pre-clinical decision making and accelerate workflows.
As organ-on-chip technology continues to advance, it is reshaping how complex biological systems are studied. Meet Wolfgang and Knut to discuss how our solutions can improve pre-clinical decision making and accelerate workflows.